Product Description
GL-3 Molecule (Prescription Only) – 30mg
Triple-Incretin Therapy for Fat Loss, Appetite Control & Metabolic Optimization
Formulation
GL-3 Core 30
3 × 10mg GL-3 Vials
Each vial contains:
-
10mg GL-3
-
1mL total volume
-
Concentration: 10mg / 1mL
Total Package Contents: 30mg GL-3 (3mL total)
Classification: Prescription Only – Requires Provider Consultation & Approval
What Is GL-3 Therapy?
GL-3 is a prescription triple-incretin therapy that activates three key metabolic pathways:
-
GLP-1 (Glucagon-Like Peptide-1)
-
GIP (Glucose-Dependent Insulinotropic Polypeptide)
-
Glucagon Receptor
By targeting all three receptors simultaneously, GL-3 provides comprehensive metabolic signaling, leading to:
-
Significant appetite suppression
-
Accelerated fat loss
-
Improved insulin sensitivity
-
Increased energy expenditure
-
Enhanced metabolic flexibility
-
Long-term body composition improvements
GL-3 represents the most advanced tier of incretin-based therapy and is typically utilized for patients requiring longer-term, provider-directed metabolic intervention and sustained fat loss.
All GL-3 products require clinical consultation and prescription approval prior to dispensing.
🔬 Key Research-Based Mechanisms
🔥 Triple-Incretin Activation for Superior Fat Loss
Simultaneous activation of GLP-1, GIP, and glucagon receptors enhances satiety and drives adipose tissue reduction.
Jastreboff et al., 2023 (NEJM) – Demonstrated up to 24.2% total body-weight reduction over 48 weeks.
🩸 Improved Glycemic Control & Insulin Sensitivity
Reduces fasting glucose, improves insulin signaling, and lowers HbA1c.
Frias et al., 2023 (Diabetes Care) – Reported HbA1c reductions up to 2.2%.
🧠 Appetite Suppression & Craving Control
Reduces central appetite signaling and food reward pathways.
Killion et al., 2022 – Demonstrated reduced hedonic eating behavior in preclinical models.
🧬 Increased Fat Oxidation & Energy Expenditure
Glucagon receptor activation increases metabolic rate and fat utilization.
Gil-Lozano et al., 2021 – Showed preservation of metabolic rate with increased fat oxidation.
⚕️ Clinical Access & Prescription Protocol
GL-3 therapy requires provider oversight and prescription approval.
-
Telehealth consultation required prior to dispensing
-
Labs may be recommended (HbA1c, fasting glucose, lipid panel, CMP)
-
Individualized dosing and titration plan
-
Ongoing provider monitoring and follow-up included
💉 Dosing Protocol (GL-3 Core 30)
Total Dose
30mg Total GL-3
Package Contents
3 × 10mg vials
Concentration
10mg / 1mL
Dosing Equivalency
10 units = 1mg GL-3
Starting Dose
20 units weekly (2mg)
Titration Strategy (Standard PROPeptides Protocol)
-
Maintain dose until 2 consecutive weeks of no weight loss
-
Increase by 10 units (1mg) when appropriate
-
If side effects occur, reduce dose by 10 units and resume titration
Administration
Route: Subcutaneous injection (abdomen preferred)
Ideal Use
The GL-3 Core 30 package is designed for patients who have progressed through the introductory and intermediate phases of therapy and are utilizing greater than 50 units (5mg) weekly as part of their provider-guided protocol.
This package is ideal for individuals requiring a higher monthly supply to support continued weight loss, body composition improvement, and metabolic optimization while minimizing the frequency of reordering.
At doses above 50 units weekly, GL-3 Core 30 typically provides approximately one month of therapy, although actual duration will vary based on individualized dosing and provider-directed titration.
Program Length
Typically utilized as part of a 3–12 month provider-guided metabolic optimization program with reassessment every 4–8 weeks.
Compatible Stacks
KPV
Supports gut health and inflammation management.
Tesamorelin
May support body composition optimization and visceral fat reduction.
MOTS-C
Supports metabolic efficiency and insulin sensitivity.
GHK-Cu
Supports recovery and tissue support.
📦 What’s Included With Every Order
-
3 × GL-3 Core 10mg vials (30mg total)
-
Insulin syringes & alcohol swabs
-
Sharps container bag
-
Printed dosing, titration, storage, and injection guide
-
Ongoing access to licensed prescribing provider
📧 Need Assistance?
480-400-6225
🛡️ Advanced Fat Loss. Triple-Pathway Precision. Clinical Oversight.
GL-3 Core 30 is designed for patients who have advanced into higher-dose therapy and require a larger monthly supply to maintain momentum toward their goals. Through triple-incretin activation and provider-guided dosing, GL-3 supports meaningful fat loss, appetite control, improved insulin sensitivity, and long-term metabolic health.
For patients seeking sustained progress with fewer interruptions, GL-3 Core 30 provides an ideal balance of dosing flexibility, value, and clinical oversight.
Directions For Use
GL-3 Molecule (Prescription Only) – 30mg
Triple-Incretin Therapy for Fat Loss, Appetite Control & Metabolic Optimization
Formulation
GL-3 Core 30
3 × 10mg GL-3 Vials
Each vial contains:
-
10mg GL-3
-
1mL total volume
-
Concentration: 10mg / 1mL
Total Package Contents: 30mg GL-3 (3mL total)
Classification: Prescription Only – Requires Provider Consultation & Approval
What Is GL-3 Therapy?
GL-3 is a prescription triple-incretin therapy that activates three key metabolic pathways:
-
GLP-1 (Glucagon-Like Peptide-1)
-
GIP (Glucose-Dependent Insulinotropic Polypeptide)
-
Glucagon Receptor
By targeting all three receptors simultaneously, GL-3 provides comprehensive metabolic signaling, leading to:
-
Significant appetite suppression
-
Accelerated fat loss
-
Improved insulin sensitivity
-
Increased energy expenditure
-
Enhanced metabolic flexibility
-
Long-term body composition improvements
GL-3 represents the most advanced tier of incretin-based therapy and is typically utilized for patients requiring longer-term, provider-directed metabolic intervention and sustained fat loss.
All GL-3 products require clinical consultation and prescription approval prior to dispensing.
🔬 Key Research-Based Mechanisms
🔥 Triple-Incretin Activation for Superior Fat Loss
Simultaneous activation of GLP-1, GIP, and glucagon receptors enhances satiety and drives adipose tissue reduction.
Jastreboff et al., 2023 (NEJM) – Demonstrated up to 24.2% total body-weight reduction over 48 weeks.
🩸 Improved Glycemic Control & Insulin Sensitivity
Reduces fasting glucose, improves insulin signaling, and lowers HbA1c.
Frias et al., 2023 (Diabetes Care) – Reported HbA1c reductions up to 2.2%.
🧠 Appetite Suppression & Craving Control
Reduces central appetite signaling and food reward pathways.
Killion et al., 2022 – Demonstrated reduced hedonic eating behavior in preclinical models.
🧬 Increased Fat Oxidation & Energy Expenditure
Glucagon receptor activation increases metabolic rate and fat utilization.
Gil-Lozano et al., 2021 – Showed preservation of metabolic rate with increased fat oxidation.
⚕️ Clinical Access & Prescription Protocol
GL-3 therapy requires provider oversight and prescription approval.
-
Telehealth consultation required prior to dispensing
-
Labs may be recommended (HbA1c, fasting glucose, lipid panel, CMP)
-
Individualized dosing and titration plan
-
Ongoing provider monitoring and follow-up included
💉 Dosing Protocol (GL-3 Core 30)
Total Dose
30mg Total GL-3
Package Contents
3 × 10mg vials
Concentration
10mg / 1mL
Dosing Equivalency
10 units = 1mg GL-3
Starting Dose
20 units weekly (2mg)
Titration Strategy (Standard PROPeptides Protocol)
-
Maintain dose until 2 consecutive weeks of no weight loss
-
Increase by 10 units (1mg) when appropriate
-
If side effects occur, reduce dose by 10 units and resume titration
Administration
Route: Subcutaneous injection (abdomen preferred)
Ideal Use
The GL-3 Core 30 package is designed for patients who have progressed through the introductory and intermediate phases of therapy and are utilizing greater than 50 units (5mg) weekly as part of their provider-guided protocol.
This package is ideal for individuals requiring a higher monthly supply to support continued weight loss, body composition improvement, and metabolic optimization while minimizing the frequency of reordering.
At doses above 50 units weekly, GL-3 Core 30 typically provides approximately one month of therapy, although actual duration will vary based on individualized dosing and provider-directed titration.
Program Length
Typically utilized as part of a 3–12 month provider-guided metabolic optimization program with reassessment every 4–8 weeks.
Compatible Stacks
KPV
Supports gut health and inflammation management.
Tesamorelin
May support body composition optimization and visceral fat reduction.
MOTS-C
Supports metabolic efficiency and insulin sensitivity.
GHK-Cu
Supports recovery and tissue support.
📦 What’s Included With Every Order
-
3 × GL-3 Core 10mg vials (30mg total)
-
Insulin syringes & alcohol swabs
-
Sharps container bag
-
Printed dosing, titration, storage, and injection guide
-
Ongoing access to licensed prescribing provider
📧 Need Assistance?
480-400-6225
🛡️ Advanced Fat Loss. Triple-Pathway Precision. Clinical Oversight.
GL-3 Core 30 is designed for patients who have advanced into higher-dose therapy and require a larger monthly supply to maintain momentum toward their goals. Through triple-incretin activation and provider-guided dosing, GL-3 supports meaningful fat loss, appetite control, improved insulin sensitivity, and long-term metabolic health.
For patients seeking sustained progress with fewer interruptions, GL-3 Core 30 provides an ideal balance of dosing flexibility, value, and clinical oversight.
Ingredients
GL-3 Molecule (Prescription Only) – 30mg
Triple-Incretin Therapy for Fat Loss, Appetite Control & Metabolic Optimization
Formulation
GL-3 Core 30
3 × 10mg GL-3 Vials
Each vial contains:
-
10mg GL-3
-
1mL total volume
-
Concentration: 10mg / 1mL
Total Package Contents: 30mg GL-3 (3mL total)
Classification: Prescription Only – Requires Provider Consultation & Approval
What Is GL-3 Therapy?
GL-3 is a prescription triple-incretin therapy that activates three key metabolic pathways:
-
GLP-1 (Glucagon-Like Peptide-1)
-
GIP (Glucose-Dependent Insulinotropic Polypeptide)
-
Glucagon Receptor
By targeting all three receptors simultaneously, GL-3 provides comprehensive metabolic signaling, leading to:
-
Significant appetite suppression
-
Accelerated fat loss
-
Improved insulin sensitivity
-
Increased energy expenditure
-
Enhanced metabolic flexibility
-
Long-term body composition improvements
GL-3 represents the most advanced tier of incretin-based therapy and is typically utilized for patients requiring longer-term, provider-directed metabolic intervention and sustained fat loss.
All GL-3 products require clinical consultation and prescription approval prior to dispensing.
🔬 Key Research-Based Mechanisms
🔥 Triple-Incretin Activation for Superior Fat Loss
Simultaneous activation of GLP-1, GIP, and glucagon receptors enhances satiety and drives adipose tissue reduction.
Jastreboff et al., 2023 (NEJM) – Demonstrated up to 24.2% total body-weight reduction over 48 weeks.
🩸 Improved Glycemic Control & Insulin Sensitivity
Reduces fasting glucose, improves insulin signaling, and lowers HbA1c.
Frias et al., 2023 (Diabetes Care) – Reported HbA1c reductions up to 2.2%.
🧠 Appetite Suppression & Craving Control
Reduces central appetite signaling and food reward pathways.
Killion et al., 2022 – Demonstrated reduced hedonic eating behavior in preclinical models.
🧬 Increased Fat Oxidation & Energy Expenditure
Glucagon receptor activation increases metabolic rate and fat utilization.
Gil-Lozano et al., 2021 – Showed preservation of metabolic rate with increased fat oxidation.
⚕️ Clinical Access & Prescription Protocol
GL-3 therapy requires provider oversight and prescription approval.
-
Telehealth consultation required prior to dispensing
-
Labs may be recommended (HbA1c, fasting glucose, lipid panel, CMP)
-
Individualized dosing and titration plan
-
Ongoing provider monitoring and follow-up included
💉 Dosing Protocol (GL-3 Core 30)
Total Dose
30mg Total GL-3
Package Contents
3 × 10mg vials
Concentration
10mg / 1mL
Dosing Equivalency
10 units = 1mg GL-3
Starting Dose
20 units weekly (2mg)
Titration Strategy (Standard PROPeptides Protocol)
-
Maintain dose until 2 consecutive weeks of no weight loss
-
Increase by 10 units (1mg) when appropriate
-
If side effects occur, reduce dose by 10 units and resume titration
Administration
Route: Subcutaneous injection (abdomen preferred)
Ideal Use
The GL-3 Core 30 package is designed for patients who have progressed through the introductory and intermediate phases of therapy and are utilizing greater than 50 units (5mg) weekly as part of their provider-guided protocol.
This package is ideal for individuals requiring a higher monthly supply to support continued weight loss, body composition improvement, and metabolic optimization while minimizing the frequency of reordering.
At doses above 50 units weekly, GL-3 Core 30 typically provides approximately one month of therapy, although actual duration will vary based on individualized dosing and provider-directed titration.
Program Length
Typically utilized as part of a 3–12 month provider-guided metabolic optimization program with reassessment every 4–8 weeks.
Compatible Stacks
KPV
Supports gut health and inflammation management.
Tesamorelin
May support body composition optimization and visceral fat reduction.
MOTS-C
Supports metabolic efficiency and insulin sensitivity.
GHK-Cu
Supports recovery and tissue support.
📦 What’s Included With Every Order
-
3 × GL-3 Core 10mg vials (30mg total)
-
Insulin syringes & alcohol swabs
-
Sharps container bag
-
Printed dosing, titration, storage, and injection guide
-
Ongoing access to licensed prescribing provider
📧 Need Assistance?
480-400-6225
🛡️ Advanced Fat Loss. Triple-Pathway Precision. Clinical Oversight.
GL-3 Core 30 is designed for patients who have advanced into higher-dose therapy and require a larger monthly supply to maintain momentum toward their goals. Through triple-incretin activation and provider-guided dosing, GL-3 supports meaningful fat loss, appetite control, improved insulin sensitivity, and long-term metabolic health.
For patients seeking sustained progress with fewer interruptions, GL-3 Core 30 provides an ideal balance of dosing flexibility, value, and clinical oversight.
Disclaimer
GL-3 Molecule (Prescription Only) – 30mg
Triple-Incretin Therapy for Fat Loss, Appetite Control & Metabolic Optimization
Formulation
GL-3 Core 30
3 × 10mg GL-3 Vials
Each vial contains:
-
10mg GL-3
-
1mL total volume
-
Concentration: 10mg / 1mL
Total Package Contents: 30mg GL-3 (3mL total)
Classification: Prescription Only – Requires Provider Consultation & Approval
What Is GL-3 Therapy?
GL-3 is a prescription triple-incretin therapy that activates three key metabolic pathways:
-
GLP-1 (Glucagon-Like Peptide-1)
-
GIP (Glucose-Dependent Insulinotropic Polypeptide)
-
Glucagon Receptor
By targeting all three receptors simultaneously, GL-3 provides comprehensive metabolic signaling, leading to:
-
Significant appetite suppression
-
Accelerated fat loss
-
Improved insulin sensitivity
-
Increased energy expenditure
-
Enhanced metabolic flexibility
-
Long-term body composition improvements
GL-3 represents the most advanced tier of incretin-based therapy and is typically utilized for patients requiring longer-term, provider-directed metabolic intervention and sustained fat loss.
All GL-3 products require clinical consultation and prescription approval prior to dispensing.
🔬 Key Research-Based Mechanisms
🔥 Triple-Incretin Activation for Superior Fat Loss
Simultaneous activation of GLP-1, GIP, and glucagon receptors enhances satiety and drives adipose tissue reduction.
Jastreboff et al., 2023 (NEJM) – Demonstrated up to 24.2% total body-weight reduction over 48 weeks.
🩸 Improved Glycemic Control & Insulin Sensitivity
Reduces fasting glucose, improves insulin signaling, and lowers HbA1c.
Frias et al., 2023 (Diabetes Care) – Reported HbA1c reductions up to 2.2%.
🧠 Appetite Suppression & Craving Control
Reduces central appetite signaling and food reward pathways.
Killion et al., 2022 – Demonstrated reduced hedonic eating behavior in preclinical models.
🧬 Increased Fat Oxidation & Energy Expenditure
Glucagon receptor activation increases metabolic rate and fat utilization.
Gil-Lozano et al., 2021 – Showed preservation of metabolic rate with increased fat oxidation.
⚕️ Clinical Access & Prescription Protocol
GL-3 therapy requires provider oversight and prescription approval.
-
Telehealth consultation required prior to dispensing
-
Labs may be recommended (HbA1c, fasting glucose, lipid panel, CMP)
-
Individualized dosing and titration plan
-
Ongoing provider monitoring and follow-up included
💉 Dosing Protocol (GL-3 Core 30)
Total Dose
30mg Total GL-3
Package Contents
3 × 10mg vials
Concentration
10mg / 1mL
Dosing Equivalency
10 units = 1mg GL-3
Starting Dose
20 units weekly (2mg)
Titration Strategy (Standard PROPeptides Protocol)
-
Maintain dose until 2 consecutive weeks of no weight loss
-
Increase by 10 units (1mg) when appropriate
-
If side effects occur, reduce dose by 10 units and resume titration
Administration
Route: Subcutaneous injection (abdomen preferred)
Ideal Use
The GL-3 Core 30 package is designed for patients who have progressed through the introductory and intermediate phases of therapy and are utilizing greater than 50 units (5mg) weekly as part of their provider-guided protocol.
This package is ideal for individuals requiring a higher monthly supply to support continued weight loss, body composition improvement, and metabolic optimization while minimizing the frequency of reordering.
At doses above 50 units weekly, GL-3 Core 30 typically provides approximately one month of therapy, although actual duration will vary based on individualized dosing and provider-directed titration.
Program Length
Typically utilized as part of a 3–12 month provider-guided metabolic optimization program with reassessment every 4–8 weeks.
Compatible Stacks
KPV
Supports gut health and inflammation management.
Tesamorelin
May support body composition optimization and visceral fat reduction.
MOTS-C
Supports metabolic efficiency and insulin sensitivity.
GHK-Cu
Supports recovery and tissue support.
📦 What’s Included With Every Order
-
3 × GL-3 Core 10mg vials (30mg total)
-
Insulin syringes & alcohol swabs
-
Sharps container bag
-
Printed dosing, titration, storage, and injection guide
-
Ongoing access to licensed prescribing provider
📧 Need Assistance?
480-400-6225
🛡️ Advanced Fat Loss. Triple-Pathway Precision. Clinical Oversight.
GL-3 Core 30 is designed for patients who have advanced into higher-dose therapy and require a larger monthly supply to maintain momentum toward their goals. Through triple-incretin activation and provider-guided dosing, GL-3 supports meaningful fat loss, appetite control, improved insulin sensitivity, and long-term metabolic health.
For patients seeking sustained progress with fewer interruptions, GL-3 Core 30 provides an ideal balance of dosing flexibility, value, and clinical oversight.